Increased coagulation activity and genetic polymorphisms in the F5, F10 and EPCRgenes are associated with breast cancer: a case-control study-Reference-Cited by-同舟云学术

Increased coagulation activity and genetic polymorphisms in the F5, F10 and EPCRgenes are associated with breast cancer: a case-control study

Published:2014-11-19 Issue:1 Volume:14 Page:
ISSN:1471-2407
Container-title:BMC Cancer
language:en
Short-container-title:BMC Cancer

Author:

Tinholt Mari,Viken Marte Kathrine,Dahm Anders Erik,Vollan Hans Kristian Moen,Sahlberg Kristine Kleivi,Garred Øystein,Børresen-Dale Anne-Lise,Jacobsen Anne Flem,Kristensen Vessela,Bukholm Ida,Kåresen Rolf,Schlichting Ellen,Skretting Grethe,Lie Benedicte Alexandra,Sandset Per Morten,Iversen Nina

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Oncology

Link

http://link.springer.com/content/pdf/10.1186/1471-2407-14-845.pdf

Reference47 articles.

1. Green D, Maliekel K, Sushko E, Akhtar R, Soff GA: Activated-protein-C resistance in cancer patients. Haemostasis. 1997, 27: 112-118.

2. Nijziel MR, van Oerle R, Christella M, Thomassen LG, van Pampus EC, Hamulyak K, Tans G, Rosing J: Acquired resistance to activated protein C in breast cancer patients. Br J Haematol. 2003, 120: 117-122. 10.1046/j.1365-2141.2003.03987.x.

3. Paspatis GA, Sfyridaki A, Papanikolaou N, Triantafyllou K, Livadiotaki A, Kapsoritakis A, Lydataki N: Resistance to activated protein C, factor V leiden and the prothrombin G20210A variant in patients with colorectal cancer. Pathophysiol Haemost Thromb. 2002, 32: 2-7. 10.1159/000057282.

4. Franchini M, Montagnana M, Favaloro EJ, Lippi G: The bidirectional relationship of cancer and hemostasis and the potential role of anticoagulant therapy in moderating thrombosis and cancer spread. Semin Thromb Hemost. 2009, 35: 644-653. 10.1055/s-0029-1242718.

5. Kohli M, Fink LM, Spencer HJ, Zent CS: Advanced prostate cancer activates coagulation: a controlled study of activation markers of coagulation in ambulatory patients with localized and advanced prostate cancer. Blood Coagul Fibrinolysis. 2002, 13: 1-5. 10.1097/00001721-200201000-00001.

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic and Therapeutic Implications of Cell Division Cycle 20 Homolog in Breast Cancer;Cancers;2024-07-15

2. Coagulation factor V in breast cancer: a p53-regulated tumor suppressor and predictive marker for treatment response to chemotherapy;Journal of Thrombosis and Haemostasis;2024-06

3. Cancer-Associated Thrombosis: Pathophysiology, Laboratory Assessment, and Current Guidelines;Cancers;2024-05-30

4. Cancer progression and tumor hypercoagulability: a platelet perspective;Journal of Thrombosis and Thrombolysis;2024-05-17

5. The breast cancer coagulome in the tumor microenvironment and its role in prognosis and treatment response to chemotherapy;Journal of Thrombosis and Haemostasis;2024-05